↓ Skip to main content

MicroRNA as an Important Target for Anticancer Drug Development

Overview of attention for article published in Frontiers in Pharmacology, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
1 X user
peer_reviews
1 peer review site

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNA as an Important Target for Anticancer Drug Development
Published in
Frontiers in Pharmacology, August 2021
DOI 10.3389/fphar.2021.736323
Pubmed ID
Authors

Zhiwen Fu, Liu Wang, Shijun Li, Fen Chen, Kathy Ka-Wai Au-Yeung, Chen Shi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 14%
Student > Ph. D. Student 11 12%
Researcher 7 8%
Unspecified 5 5%
Other 3 3%
Other 8 9%
Unknown 44 48%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 25%
Unspecified 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Medicine and Dentistry 3 3%
Chemistry 3 3%
Other 4 4%
Unknown 49 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2022.
All research outputs
#15,155,790
of 23,310,485 outputs
Outputs from Frontiers in Pharmacology
#5,445
of 16,763 outputs
Outputs of similar age
#232,161
of 430,329 outputs
Outputs of similar age from Frontiers in Pharmacology
#285
of 981 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,763 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,329 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 981 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.